Therma Bright Inc. THRBF Archives

WednesdaySep 04, 2019 10:33 am

QualityStocksNewsBreaks – Therma Bright Inc.’s (TSX.V: THRM) (OTC: THRBF) TherOZap(TM) Technology Proven Successful at Inhibiting Zika Virus During In-Vitro Tests

Medical device technology provider Therma Bright (TSX.V: THRM) (OTC: THRBF) this morning announced that its TherOZap(TM) Technology has been proven successful at inhibiting the Zika virus during in-vitro tests. According to the update, Therma engaged a top Virology Research Laboratory in Canada to study the ability of its TherOZap(TM) technology to inactivate live Zika virus in culture media and to determine inhibition of the Zika virus infection in-vitro in selected cell cultures. Study researchers stated that, “the in-vitro testing has shown that a short heat pulse from the TherOZap(TM) device dramatically inhibits the production of infectious Zika virus in multiple…

WednesdayJul 03, 2019 9:32 am

QualityStocksNewsBreaks – Therma Bright Inc. (TSX.V: THRM) (OTC: THRBF) Announces Continued Testing of TherOZap Technology Against Zika Virus

Progressive medical device technology company Therma Bright Inc. (TSX.V: THRM) (OTC: THRBF) this morning announced that it continues to test its TherOZap technology against the Zika virus, following the advice of one of the top research laboratories in Canada. Per the update, a number of additional parameters have been added to the testing regime, with an aim of producing statistically relevant results. The company intends to report further information as it becomes available. “Therma Bright is awaiting the results of the current testing of its proprietary TherOZap technology against the Zika virus. We appreciate the prudence and thorough approach being…

TuesdayApr 02, 2019 11:09 am

Therma Bright Inc. (TSX.V: THRM) (OTC: THRBF) Set to Thrive within Blossoming Cosmeceutical Industry

Therma Bright Inc.’s proprietary technology has received Class II medical device status from the U.S. Food and Drug Administration The global market for cosmeceuticals was valued at nearly $47 billion in 2017 and is estimated to see continued growth The company is waiting on regulatory approvals for its thermal therapy technology, which incorporates the use of cannabis or cannabidiol Therma Bright Inc. (TSX.V: THRM) (OTC: THRBF), a medical device technology provider focused on addressing dermatological needs in the multi-billion-dollar cosmeceutical (the convergence of cosmetic and pharmaceutical products) industry, offers relief for insect and marine life bites and stings, which is…

MondayApr 01, 2019 1:23 pm

Therma Bright Inc. (TSX.V: THRM) (OTC: THRBF) Readies Online Sales Strategy for New InterceptCS Cold Sore Prevention Device

THRBF offers an IoT- and Bluetooth-enabled device for cold-sore prevention Its sales strategy is part of the company’s larger focus on developing products for the dermatology market THRBF’s proprietary technology is designed to prevent cold sores in the OTC sector, which is projected to record significant sales growth Therma Bright Inc. (TSX.V: THRM) (OTC: THRBF) is offering a new generation of technology in the burgeoning skin care market. The company is specifically planning to target sales growth for its high gross-margin InterceptCS* cold sore prevention device with a new website, social media campaign and online sales strategy (http://ibn.fm/qqEgF). THRBF’s new InterceptCS…

ThursdayMar 28, 2019 11:34 am

QualityStocksNewsBreaks – Therma Bright Inc.’s (TSX.V: THRM) (OTC: THRBF) TherOZap(TM) Technology in Final Stage Testing Against Zika Virus

Medical device technology provider Therma Bright (TSX.V: THRM) (OTC: THRBF) this morning announced that it is in the final stages of in vitro testing and awaits the results of the TherOZap(TM) technology against the Zika virus. According to the update, a top research laboratory in Canada is conducting the testing, and Therma Bright expects to report further information as it becomes available. “To date the research lab has done an excellent job following protocol and testing our device with the aim of reporting statistically relevant results,” Therma Bright CEO Rob Fia stated in the news release. “Therma Bright made a…

FridayMar 08, 2019 3:04 pm

QualityStocksNewsBreaks – Therma Bright Inc. (TSX.V: THRM) (OTC: THRBF) Employs Trademarked Infrared Heat Technology to Protect the Body’s Largest Organ

Therma Bright (TSX.V: THRM) (OTC: THRBF) is focused on protecting the human body’s largest and fastest-growing organ, skin, which is a vital guard against damage to all other organs. An article discussing the company reads, “Therma Bright Inc. (TSX.V: THRM) (OTC: THRBF) is focusing its business mission on the development of innovative technologies that strengthen and sustain the body’s outer layer and help people to live healthier lives as a result. . . . The key to Therma Bright’s vision of enhancing health and wellness is to employ trademarked infrared heat technology against agents that attack the skin, such as…

FridayMar 01, 2019 3:01 pm

QualityStocksNewsBreaks – Therma Bright Inc. (TSX.V: THRM) (OTC: THRBF) Targets $10.7B Skin Care Device Market with Innovative Products and Technology

Therma Bright (TSX.V: THRM) (OTC: THRBF) targets the $10.7 billion skin-care device market with products that leverage innovative technology to address dermatological needs. A recent article discussing the company reads, “The foundation of Therma Bright’s noninvasive, pain-free skin care offerings is proprietary technology that has received class II medical device status from the U.S. Food and Drug Administration (‘FDA’). The company’s products include the InteceptCS Cold Sore Prevention Device and the TherOZap Insect Bite Treatment Device. One focus of Therma Bright’s products, devices and treatments is providing relief of pain, itch and inflammation resulting from over 20,000 kinds of insect…

ThursdayFeb 28, 2019 12:09 pm

Therma Bright Inc. (TSX.V: THRM) (OTC: THRBF) Building Health and Wellness Profile by Prioritizing Skin Care

Cosmeceutical industry forecasts anticipate $73 billion market for cosmetic skin care products utilizing active chemical ingredients by 2023 Therma Bright is using trademarked infrared head technologies to target skin viruses and establish a protective barrier for the human body’s largest organ Company is also exploring cannabidiol’s properties as augmenting agent for thermal technologies in fighting pain Far from being mere tissue, skin is the human body’s largest and fastest-growing organ and a vital protection against harm to all of the body’s other organs and the systems that regulate their function (http://ibn.fm/4AO39), which provides an obvious reason for trying to keep skin…

MondayFeb 25, 2019 11:10 am

Therma Bright Inc. (TSX.V: THRM) (OTC: THRBF) Addressing Dermatological Needs with Premier Medical Devices

Therma Bright’s products target the multi-billion dollar skin care device market Its non-invasive, pain-free skin care offerings are based on proprietary technology Therma Bright currently has two products on the market, plus an additional one in development Therma Bright Inc. (TSX.V: THRM) (OTC: THRBF) concentrates on providing first-rate medical devices that address dermatological needs. At present, the company has two products on the market and one in the research and development phase. Its portfolio includes products, devices and treatments that have cosmetic and medicinal or therapeutic benefits. Based in Toronto, Ontario, Therma Bright has significant investments in intellectual property and…

WednesdayFeb 20, 2019 11:20 am

Therma Bright Inc. (TSX.V: THRM) (OTC: THRBF) Testing Innovative Products for Pain Relief Solutions

The 1980s gave birth to the notion that opioids could be widely prescribed as non-addictive and quality-of-life enhancing drugs Therma Bright is testing its trademarked infrared heat therapy with cannabidiol to combat general and chronic pain The company is also making strides in testing a way to combat mosquito-borne viruses Media attention to the so-called “opioid crisis” has sparked a new confluence of research and policy as medical professionals reevaluate existing prescriber practices for pain medications, advocates drive social change in drug use perspectives and politicians ponder best legislative practices for a wide variety of constituents. As non-addictive cannabidiol (“CBD”)…

Site Search

Company Search

Tag: Therma Bright Inc. THRBF